Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 25: The MyPEAK-1 Study
Author(s): Milind Y Desai Added: 1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene… View more

Heart Failure
Ep 132: The Heart of the Game: Cardiovascular Risk in Athletes
Added: 1 year ago
In this illuminating episode of Parallax, Dr Ankur Kalra engages with Dr Jonathan Drezner, Director of Sports Cardiology at the University of Washington, who explores the complex world of cardiovascular risk in competitive athletes.Dr Drezner traces the evolution of sports cardiology from watershed moments involving high-profile athletes like Hank Gathers and Reggie Lewis to today's sophisticated… View more

Heart Failure
AHA Scientific Sessions 2025 Late-Breaking and Featured Science Collection
Author(s): Nicolas M Van Mieghem Added: 5 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for… View more

Intervention

Cardiovascular Kidney Metabolic
CMR Phenotyping More Accurately Predicts Arrhythmic Risk in Cardiac Sarcoidosis
Added: 7 months ago Source:  Radcliffe Cardiology
AUTHOR: Jordan RanceRisk stratification for primary prevention implantable cardioverter-defibrillator (ICD) placement in patients with cardiac sarcoidosis remains a clinical challenge, partly due to inconsistencies in diagnostic criteria and the variable course of the disease. A new study published in the European Heart Journal suggests that cardiovascular magnetic resonance (CMR) phenotyping has… View more

Imaging & Diagnostics

Electrophysiology & Arrhythmia
Research Area(s) / Expertise: Job title: Consultant Cardiologist
DrPatricia Campbell is aConsultant Cardiologist atCraigavon Area hospital, Portadown, UK. Dr Campbell's published research focuses on HF hemodynamics, the right heart in HF and optimal clinical pathways for HF patients. View more
AHA 2024 Late-Breaking and Featured Science Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Keep up-to-date with our video collection covering the American Heart Association's 2024 Scientific Sessions in Chicago. For expert insights on the hottest late-breaking and featured science trials, tune in to our collection.To catch reviews on the most awaited trials, watch our recurring series View From the ThoraxCenter, hosted by Prof Nicolas Van Mieghem andDr Joost Daemen (Thoraxcenter,… View more

Intervention

Prevention & Chronic Conditions
Mariya Tokmakova
Research Area(s) / Expertise: Job title: Head of Department at the Cardiology Clinic University Hospital & Vice-Rector for Scientific and Research Activities at the Medical University of Plovdiv
Prof Mariya Tokmakova is Vice-Rector for Scientific and Research Activities at the Medical University of Plovdiv, where she also serves as Head of the Cardiology Clinic at University Hospital St Georgi and is a member of the Academic Staff at the Department of Cardiology. She was appointed Professor of Cardiology in 2022, following earlier academic appointments including Associate Professor in… View more
ESC 25: The ODYSSEY-HCM Study
Author(s): Milind Y Desai Added: 8 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a… View more

Heart Failure
Increasing VA-ECMO Flow Does Not Typically Raise Pulmonary Capillary Wedge Pressure in Cardiogenic Shock
Added: 7 months ago Source:  Radcliffe Cardiology
New research challenges the common assumption that high flow rates during venoarterial extracorporeal membrane oxygenation (VA-ECMO) increase pulmonary capillary wedge pressure (PCWP) and the risk of pulmonary oedema in patients with cardiogenic shock. The ECMO-Flow trial found that increasing VA-ECMO flow often has a neutral or even beneficial effect on PCWP, despite raising left ventricular… View more

Imaging & Diagnostics

Heart Failure
RSV Vaccine Effective in Patients With ASCVD: DAN-RSV
Added: 5 months ago Source:  Radcliffe Cardiology
A prespecified secondary analysis of the DAN-RSV trial has found that a bivalent respiratory syncytial virus (RSV) vaccine is similarly effective against respiratory and cardiovascular outcomes in older adults, regardless of pre-existing atherosclerotic cardiovascular disease (ASCVD).¹The bivalent RSV prefusion F protein-based (RSVpreF) vaccine contains stabilised prefusion F glycoproteins from… View more

Demographic

Heart Failure